Written by
Phil Grainger
Poornima Anil
Bhvita Jani
Max Street
Share article:
In July, The Centers for Medicare & Medicaid Services (CMS) released its 2025 Hospital Outpatient Prospective Payment System (OPPS) proposed rule, which included the proposal to pay for CT-based colon cancer screening.
Why we chose this topic
- Colorectal cancer is the third most common cancer worldwide and is the second leading cause of cancer-related deaths, according to the World Health Organisation.
- CT-based colon cancer screening has the potential to increase participation, but inconsistencies in its reimbursement have limited access to the procedure.
Why it matters
- The change in CMS policy is a controversial move, with considerable opposition to the use of CTC in screening.
- The proposal also highlights other dichotomies in relation to screening programmes.
- It has potential commercial ramifications for modality and AI vendors.
Read the full insight with a Signify Premium Insights - Medical Imaging subscription
